ReviewFrontiers in gastroenterology (Lausanne, Switzerland)2026
Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.
Shannon Fernando et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.